Previous close | 5.030 |
Open | 5.140 |
Bid | 5.030 x N/A |
Ask | 5.050 x N/A |
Day's range | 5.030 - 5.220 |
52-week range | 3.540 - 8.700 |
Volume | |
Avg. volume | 1,292,904 |
Market cap | 5.986B |
Beta (5Y monthly) | 0.31 |
PE ratio (TTM) | 6.99 |
EPS (TTM) | 0.720 |
Earnings date | 28 Mar 2024 |
Forward dividend & yield | 0.10 (1.99%) |
Ex-dividend date | 03 Jul 2024 |
1y target est | 8.40 |
The World Bank recently released its updated "Global Economic Outlook" report, projecting a 2.1% global economic growth for 2023. This forecast represents an upward revision of 0.4 percentage points compared to the previous prediction in January, yet it still falls short of the 3.1% growth anticipated for 2022. At present, the global economy remains in a recovery phase, and businesses continue to confront a multitude of risks. In the post-pandemic era, it becomes particularly essential for compa
June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi Biologics.